Substituted tetralins, chromans and related compounds in the treatment of asthma
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 26, 2000
Grant Date -
N/A
app pub date -
Apr 11, 1990
filing date -
Oct 19, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Substituted tetralins, chromans and related compounds which, by inhibiting 5-lipoxygenase enzyme and/or blocking leukotriene receptors, are useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction and related disease states in mammals; pharmaceutical compositions comprising said compounds; a method of treatment with said compounds; and intermediates useful in the synthesis of said compounds.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully